The panel's recommendation is intended to prevent genital
warts and anal cancers in males, and possibly prevent head and neck cancer (though the vaccine's effectiveness against head and neck cancers has not yet been proven).
The rationale behind the recommendation is that the vaccine prevents genital
warts and anal cancers in males, both of which can be caused by HPV
Not exact matches
HPV is also associated with genital
warts and vulvar, vaginal, penile,
anal and oropharyngeal cancers.
«Based on epidemiological studies, the 9vHPV vaccine could prevent approximately 90 percent of cervical cancer, 90 percent of HPV - related vulvar
and vaginal cancer, 70 to 85 percent of high - grade cervical disease in females,
and approximately 90 percent of HPV - related
anal cancer
and genital
warts in males
and females worldwide,» explained Anna R. Giuliano, Ph.D., Director of the Center for Infection Research in Cancer at Moffitt.
HPV causes ailments such as genital
and anal warts and, in some instances, continued infection can lead to the development of benign or cancerous growths of the cervix, vulva, vagina, anus, penis, tonsils,
and base of the tongue.
HPV infection can cause cervical, head
and neck,
and anal cancers, plus genital
warts.
HPV is responsible for triggering genital
warts as well as cervical, vaginal, vulvar,
anal,
and oropharyngeal cancers.
Genital herpes has been associated with an increased risk of HIV,
and HPV can cause genital
warts as well as a higher risk of
anal, cervical (in women),
and penile cancers.
You get genital
warts from having skin - to - skin contact with someone who's infected, often during vaginal,
anal,
and oral sex.
The HPV vaccine protects you against the 9 types responsible for 90 % of cervical
and anal cancer cases, along with 90 % of genital
warts cases.